Skip to content

Oxybuprocaine for apraxia of lid opening in Parkinson's disease

Oxybuprocaine for apraxia of lid opening in Parkinson's disease - Oxybuprocain for ALO

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000017695
Enrollment
10
Registered
2015-05-27
Start date
2013-01-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

apraxia of lid opening in Parkinson&#39

Interventions

Arm 1 intervention consisted of 4%oxybuprocaine eye drop treatment, washout for 24 hours or more, and a saline eye drop treatment Arm 2 intervention consisted of saline eye drop treatment, a washout p

Sponsors

Utano National Hospital, National Hospital Organization
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: PD patients with ALO. The ALO criteria were the following: 1) transitory inability to initiate lid opening; 2) no findings of ongoing orbicularis oculi contractions, such as lowering of the brows beneath the superior orbital margins; 3) vigorous frontalis contraction during the period of inability to raise eyelids; and 4) no ocular motor or ocular sympathetic nerve dysfunction or ocular myopathy.

Exclusion criteria

Exclusion criteria: 1) corneal disease such as keratitis, corneal erosion, or ulcers; 2) treatment with botulinum toxin A during the previous 4 months; 3) hypersensitivity to oxybuprocaine hydrochloride; and 4) baseline complete opening time (COT) < 1 second.

Design outcomes

Primary

MeasureTime frame
The change of "complete opening time (COT) after 10-second eye closure" (at 13 minutes after eye drops from baseline)

Secondary

MeasureTime frame
The percentage change of COT from baseline

Countries

Japan

Contacts

Public ContactMasayuki Kohsaka

Utano National Hospital, National Hospital Organization Clinical Research Center

kousaka@unh.hosp.go.jp81-75-461-5121

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026